Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amyris Inc (AMRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Amyris, Inc. Investors (AMRS)

Law Offices of Howard G. Smith announces an investigation on behalf of Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) investors concerning the Company and its officers' possible violations of...

AMRS : 1.96 (-6.22%)
Amyris to Present at H.C. Wainwright Global Life Sciences Conference on April 8, 2019

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management...

AMRS : 1.96 (-6.22%)
Bragar Eagel & Squire, P.C. is Investigating Amyris, Inc. (AMRS) on Behalf of Stockholders and Encourages AMRS Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against Amyris, Inc. (NASDAQ: AMRS). Our investigation concerns whether Amyris has violated the federal securities laws and/or engaged in...

AMRS : 1.96 (-6.22%)
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Amyris, Inc. Investors (AMRS)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) investors concerning the Company and its officers' possible violations...

AMRS : 1.96 (-6.22%)
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Amyris, Inc.Investors (AMRS)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Amyris, Inc.("Amyris" or the "Company") (NASDAQ: AMRS) investors concerning the Company and its officers' possible...

AMRS : 1.96 (-6.22%)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Amyris, Inc.Investors (AMRS)

Law Offices of Howard G. Smithannounces an investigation on behalf of Amyris, Inc.("Amyris" or the "Company") (NASDAQ: AMRS) investors concerning the Company and its officers' possible violations...

AMRS : 1.96 (-6.22%)
Amyris Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Announces Signing of $300 Million Definitive Cannabinoid Agreement

EQNX::TICKER_START (NASDAQ:AMRS), EQNX::TICKER_END

AMRS : 1.96 (-6.22%)
Amyris Finalizes Cannabinoid Development, Licensing and Commercialization Agreement Containing $300 Million of R&D and Milestone Payments and a Long-Term Royalty Stream

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has signed...

AMRS : 1.96 (-6.22%)
Amyris to Present at 31st Annual Roth Conference on Tuesday, March 19, 2019

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management...

AMRS : 1.96 (-6.22%)
Analysts Estimate Amyris (AMRS) to Report a Decline in Earnings: What to Look Out for

Amyris (AMRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMRS : 1.96 (-6.22%)
Amyris to Announce Fourth Quarter and Fiscal Year 2018 Financial Results on Monday, March 18, 2019

Amyris, Inc. (Nasdaq:AMRS) will report financial results for the fourth quarter and fiscal year ended December 31, 2018 after market close on Monday, March 18, 2019.

AMRS : 1.96 (-6.22%)
Amyris Is Selected by NIH Grant Recipient, IDRI, to Engineer Molecules for Vaccine Adjuvant Applications

Sustainable Squalene Replacement Needed for Pharma

AMRS : 1.96 (-6.22%)
Amyris Appoints Industry Veteran as President, Sweeteners and Ingredients, to Deliver Accelerated Growth

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the appointment...

AMRS : 1.96 (-6.22%)
These 4 Marijuana Stocks Could Be Positioned For A Big Month

CORAL GABLES, FL / ACCESSWIRE / February 8, 2019 / The market, as many have come to recognize, has existed for a short period of time relative to other more established markets. Due to this fact, there...

AMRS : 1.96 (-6.22%)
BIO.CN : 0.640 (unch)
PYX : 26.65 (+0.91%)
Thinking about buying stock in Amyris Inc., Disney, Electronic Arts, Trevena Inc. or Take-Two Interactive?

InvestorsObserver issues critical PriceWatch Alerts for AMRS, DIS, EA, TRVN, and TTWO.

TRVN : 1.62 (+1.25%)
AMRS : 1.96 (-6.22%)
EA : 103.78 (+2.02%)
TTWO : 97.73 (+1.77%)
DIS : 109.75 (+1.82%)
What Is Amyris (AMRS), And Why Is Its Stock Soaring?

Shares of bioscience firm Amyris (AMRS) skyrocketed more than 70% on Tuesday after the company announced a collaboration deal focused on developing, licensing, and commercializing cannabinoid products....

AMRS : 1.96 (-6.22%)
These Marijuana Stocks Should Be On Your Radar

CORAL GABLES, FL / ACCESSWIRE / February 5, 2019 / The market has managed to demonstrate its strength despite the fact that, at times, the conversation surrounding cannabis has been less than beneficial....

IMLFF : 0.4235 (-1.51%)
AMRS : 1.96 (-6.22%)
INNPF : 0.5400 (-1.82%)
NAB.CN : 0.740 (-1.33%)
IN.TO : 0.58 (unch)
PYX : 26.65 (+0.91%)
Amyris Announces Signing of Nutritional Product Royalty Agreement

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has signed...

AMRS : 1.96 (-6.22%)
Amyris Receives GRAS Notification from FDA for its New, Sugarcane-Derived, Zero Calorie Sweetener

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, announced today that it has received...

AMRS : 1.96 (-6.22%)
Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand

Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of pure, sustainable, fermentation-derived ingredients for Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today...

AMRS : 1.96 (-6.22%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ +0.05
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar